High expression of cyclin B1 predicts a favorable outcome in patients with follicular lymphoma

Nonparametric Estimation from Incomplete Observations

1992 • 45,923 citations

Nonparametric Estimation from Incomplete Observations

1958 • 37,219 citations

Regression Models and Life-Tables

1992 • 27,454 citations

Regression Models and Life-Tables

1972 • 27,145 citations

A Predictive Model for Aggressive Non-Hodgkin's Lymphoma

1993 • 4,650 citations

Report of the Committee on Hodgkin's Disease Staging Classification.

1971 • 4,212 citations

A predictive model for aggressive non-Hodgkin's lymphoma

1993 • 3,483 citations

WHO Handbook for Reporting Results of Cancer Treatment

1982 • 2,214 citations

Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues

2003 • 2,031 citations

Follicular lymphoma international prognostic index.

2004 • 1,553 citations

Cdi1, a human G1 and S phase protein phosphatase that associates with Cdk2

1993 • 1,531 citations

Follicular lymphoma international prognostic index

2006 • 1,262 citations

Hydroxyldaunomycin (adriamycin) combination chemotherapy in malignant lymphoma

1976 • 837 citations

Role of Hec1 in Spindle Checkpoint Signaling and Kinetochore Recruitment of Mad1/Mad2

2002 • 426 citations

Amplification and Deletion of Topoisomerase IIα Associate with ErbB-2 Amplification and Affect Sensitivity to Topoisomerase II Inhibitor Doxorubicin in Breast Cancer

2000 • 388 citations

Checkpoint Protein BubR1 Acts Synergistically with Mad2 to Inhibit Anaphase-promoting Complex

2002 • 332 citations

Phosphorylation by Cdc28 Activates the Cdc20-Dependent Activity of the Anaphase-Promoting Complex

2000 • 290 citations

Histone H3 phosphorylation and expression of cyclins A and B1 measured in individual cells during their progression through G2 and mitosis

1998 • 263 citations

Prognostic significance of the Ki-67-associated proliferative antigen in aggressive non-Hodgkin's lymphomas: a prospective Southwest Oncology Group trial

1994 • 236 citations

Crystal Structure and Mutational Analysis of the Human CDK2 Kinase Complex with Cell Cycle–Regulatory Protein CksHs1

1996 • 236 citations

Stage I and II Follicular Non-Hodgkin’s Lymphoma: Long-Term Follow-Up of No Initial Therapy

2004 • 232 citations

Relationship of p53, bcl-2, and Tumor Proliferation to Clinical Drug Resistance in Non-Hodgkin's Lymphomas

1997 • 230 citations

Prognostic significance of the Ki-67-associated proliferative antigen in aggressive non-Hodgkin's lymphomas: a prospective Southwest Oncology Group trial

1994 • 203 citations

Protein phosphatase 2A regulates MPF activity and sister chromatid cohesion in budding yeast

1996 • 185 citations

RHAMM Is a Centrosomal Protein That Interacts with Dynein and Maintains Spindle Pole Stability

2003 • 184 citations

Prognostic value of cellular proliferation and histologic grade in follicular lymphoma

1995 • 178 citations

A significant diffuse component predicts for inferior survival in grade 3 follicular lymphoma, but cytologic subtypes do not predict survival

2003 • 140 citations

Identification of cytogenetic subgroups and karyotypic pathways of clonal evolution in follicular lymphomas

2003 • 139 citations

Soluble hyaluronan receptor RHAMM induces mitotic arrest by suppressing Cdc2 and cyclin B1 expression.

1996 • 135 citations

Mantle cell lymphomas express a distinct genetic signature affecting lymphocyte trafficking and growth regulation as compared with subpopulations of normal human B cells.

2002 • 123 citations

Gene Expression Profile of Serial Samples of Transformed B-Cell Lymphomas

2003 • 123 citations

Clinicopathologic Correlations of Genomic Gains and Losses in Follicular Lymphoma

2002 • 94 citations

Gene expression profiling of favorable histology Wilms tumors and its correlation with clinical features.

2002 • 93 citations

Timing of APC/C substrate degradation is determined by fzy/fzr specificity of destruction boxes

2002 • 84 citations

Prognostic Significance of Ki-67 Nuclear Proliferative Antigen, bcl-2 Protein, and p53 Expression in Follicular and Diffuse Large B-Cell Lymphoma

2001 • 82 citations

Prognostic significance of bcl-xL gene expression and apoptotic cell counts in follicular lymphoma

2003 • 67 citations

Topoisomerase IIα expression in mantle cell lymphoma: a marker of cell proliferation and a prognostic factor for clinical outcome

2004 • 63 citations

Expression of bcl-6 and CD10 Protein Is Associated With Longer Overall Survival and Time to Treatment Failure in Follicular Lymphoma

2004 • 54 citations

Oncoprotein MDM2 overexpression is associated with poor prognosis in distinct non-Hodgkin's lymphoma entities.

1999 • 48 citations

Prognostic significance of proliferative and apoptotic fractions in low grade follicle center cell-derived non-Hodgkin's lymphomas

1996 • 37 citations

CDK1 and Cyclin A Expression is Linked to Cell Proliferation and Associated with Prognosis in Non-Hodgkin's Lymphomas

1999 • 32 citations

Increased expression of Ki-67 in mantle cell lymphoma is associated with de-regulation of several cell cycle regulatory components, as identified by global gene expression analysis.

2004 • 31 citations

Recruitment of cdc2 kinase by DNA topoisomerase II is coupled to chromatin remodeling

2001 • 26 citations

Current treatment of follicular non-Hodgkin's lymphoma

2002 • 26 citations

Prognostic significance of t(14;18) and bcl-2 gene expression in follicular small cleaved cell lymphoma and diffuse large cell lymphoma.

1997 • 25 citations

Expression of Cyclin B1 and cdc2 in Nodal Non-Hodgkin's Lymphoma and its Prognostic Implications

2002 • 20 citations

Prolonged Survival in Follicular Non Hodgkins Lymphoma is Predicted by Achievement of Complete Remission with Initial Treatment: Results of a Long Term Study with Multivariate Analysis of Prognostic Factors

1996 • 17 citations